In 2020, despite the COVID-19 impact, revenue should decrease by around 2.5% yoy organically. Beyond the pandemic crisis, Millicom remains an interesting ‘growth’ story (further boosted by acquisitions) in a sector which experiences none. Management’s medium-term goal (confirmed after the Q2 release) is indeed to deliver mid single-digit organic service revenue growth and mid-to-high single-digit organic EBITDA growth. We remain at Buy on the stock.
30 Jul 2020
Just a temporary delay
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Just a temporary delay
- Published:
30 Jul 2020 -
Author:
Jean-Michel Salvador -
Pages:
3
In 2020, despite the COVID-19 impact, revenue should decrease by around 2.5% yoy organically. Beyond the pandemic crisis, Millicom remains an interesting ‘growth’ story (further boosted by acquisitions) in a sector which experiences none. Management’s medium-term goal (confirmed after the Q2 release) is indeed to deliver mid single-digit organic service revenue growth and mid-to-high single-digit organic EBITDA growth. We remain at Buy on the stock.